Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Active, not recruiting	Phase 1 / Phase 2	2024-11-08		NCT04430192

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
E.J. Whitten Foundation Prostate Cancer Research Centre	1
Endocyte	3
Medical Research Future Fund	16
Movember Foundation	6
Peter MacCallum Cancer Centre, Australia	48

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peter MacCallum Cancer Centre	Melbourne	Australia	149